---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-24-009677"
form_type: "8-K"
ticker: "FBIO"
cik: "0001429260"
company_name: "Fortress Biotech, Inc."
filed_at: "2024-07-05T23:59:59+00:00"
generated_at: "2026-05-31T23:19:33.627557+00:00"
event_type: "dividend"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Fortress Biotech pauses monthly dividend on Series A Preferred Stock

## Summary
- Dividend of $0.1953125/share on 9.375% Series A Cumulative Redeemable Perpetual Preferred Stock paused effective July 1, 2024; no payment on July 31, 2024.
- Pause defers approximately $0.7 million in cash dividend payments per month; dividends continue to accrue and cumulate.
- Board will reassess regularly based on profitability and cash flow; cited upcoming potential regulatory approvals (DFD-29, cosibelimab, CUTX-101, and CAEL-101) as inflection points.
- CEO Lindsay Rosenwald noted the pause aims to maintain financial flexibility ahead of up to four potential NDA/BLA submissions or approvals in the next 12-18 months.

## SEC filing metadata
- accession: 0001558370-24-009677
- form_type: 8-K
- ticker: FBIO
- cik: 0001429260
- company_name: Fortress Biotech, Inc.
- filed_at: 2024-07-05T23:59:59+00:00
- event_type: dividend
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1429260/000155837024009677/0001558370-24-009677-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1429260/000155837024009677/fbio-20240705x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-24-009677
- JSON: https://secwatch.observer/filing/0001558370-24-009677.json
- Plain text: https://secwatch.observer/filing/0001558370-24-009677.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.